HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grazioli, L. Articles by Madariaga, J. Search for Related Content PubMed PubMed Citation Articles by Grazioli, L. Articles by Madariaga, J.

Liver Adenomatosis: Clinical, Histopathologic, and Imaging Findings in 15 Patients¹

¹ From the Departments of Radiology (L.G., M.P.F., T.I., E.B.), Pathology (M.N.), and Surgery (J.M.), University of Pittsburgh Medical Center, Presbyterian Hospital, 200 Lothrop St, Room 4660 CHP MT, Pittsburgh, PA 15213; the Department of Radiology, Spedali Civili Brescia, Italy (L.G.); and the Department of Radiology, Yamanashi Medical University, Nakakoma, Japan (T.I.). Received September 15, 1999; revision requested October 14; revision received November 9; accepted November 16. Address correspondence to M.P.F. (e-mail: federlemp@radserv.arad.upmc.edu).

PURPOSE: To report and correlate the clinical, histopathologic, and imaging findings in 15 patients with liver adenomatosis.

MATERIALS AND METHODS: Fifteen adult patients had more than 10 hepatic adenomas each and no history of glycogen storage disease or anabolic steroid use. Ten of them underwent bolus-enhanced dynamic computed tomography (CT) with or without magnetic resonance (MR) imaging, ultrasonography, and/or angiography.

RESULTS: Clinical abnormalities included abdominal pain in 11 (73%) and hepatomegaly in 10 (67%) patients, and abnormal liver function in 10 (91%) of 11 patients. The number of adenomas in each patient was 10–50 at imaging, but many more lesions were found in the resected specimens. Hemorrhage was commonly found within adenomas at histopathologic analysis, but only four patients had clinical and imaging evidence of substantial hemorrhage. In all patients, the adenomas increased over time, and two patients developed hepatocellular carcinoma. CT and MR features of the adenomas included evidence of hypervascularity (63%), intratumoral fat (50% of patients at CT, 80% at MR), and decreased conspicuity at portal venous and delayed-phase imaging. Fifty percent of patients had congenital or acquired hepatic vascular abnormalities.

CONCLUSION: The imaging and histopathologic features of individual adenomatous lesions are similar to those reported in young women who are taking oral contraceptives. However, the lesions in liver adenomatosis are not steroid dependent but rather multiple, progressive, and symptomatic, and they are more likely to lead to impaired liver function, hemorrhage, and perhaps malignant degeneration.

Index terms: Computed tomography (CT), phase imaging, 761.12112, 761.12114, 761.12115 • Liver neoplasms, 761.3192, 761.323 • Liver neoplasms, angiography, 761.124 • Liver neoplasms, CT, 761.12112, 761.12114, 761.12115 • Liver neoplasms, MR, 761.121411, 761.121412, 761.121414 • Liver neoplasms, US, 761.12983 • Magnetic resonance (MR), chemical shift

This article has been cited by other articles:

				O. Giovanoli, M. Heim, L. Terracciano, G. Bongartz, and H. P. Ledermann MRI of Hepatic Adenomatosis: Initial Observations with Gadoxetic Acid Contrast Agent in Three Patients Am. J. Roentgenol., May 1, 2008; 190(5): W290 - W293. [Abstract] [Full Text] [PDF]

				M. Svrcek, E. Jeannot, L. Arrive, R. Poupon, G. Fromont, J.-F. Flejou, J. Zucman-Rossi, P. Bouchard, and D. Wendum Regressive liver adenomatosis following androgenic progestin therapy withdrawal: a case report with a 10-year follow-up and a molecular analysis Eur. J. Endocrinol., June 1, 2007; 156(6): 617 - 621. [Abstract] [Full Text] [PDF]

				M. Lewin, A. Handra-Luca, L. Arrive, D. Wendum, V. Paradis, E. Bridel, J.-F. Flejou, J. Belghiti, J.-M. Tubiana, and V. Vilgrain Liver Adenomatosis: Classification of MR Imaging Features and Comparison with Pathologic Findings Radiology, November 1, 2006; 241(2): 433 - 440. [Abstract] [Full Text] [PDF]

				L. Grazioli, G. Morana, M. A. Kirchin, and G. Schneider Accurate Differentiation of Focal Nodular Hyperplasia from Hepatic Adenoma at Gadobenate Dimeglumine-enhanced MR Imaging: Prospective Study Radiology, July 1, 2005; 236(1): 166 - 177. [Abstract] [Full Text] [PDF]

				D. V. Sahani and S. P. Kalva Imaging the Liver Oncologist, July 1, 2004; 9(4): 385 - 397. [Abstract] [Full Text] [PDF]

				Y. Reznik, T. Dao, R. Coutant, L. Chiche, E. Jeannot, S. Clauin, P. Rousselot, M. Fabre, F. Oberti, A. Fatome, et al. Hepatocyte Nuclear Factor-1{alpha} Gene Inactivation: Cosegregation between Liver Adenomatosis and Diabetes Phenotypes in Two Maturity-Onset Diabetes of the Young (MODY)3 Families J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1476 - 1480. [Abstract] [Full Text] [PDF]

				V. Vilgrain, F. Uzan, G. Brancatelli, M. P. Federle, M. Zappa, and Y. Menu Prevalence of Hepatic Hemangioma in Patients with Focal Nodular Hyperplasia: MR Imaging Analysis Radiology, October 1, 2003; 229(1): 75 - 79. [Abstract] [Full Text] [PDF]

				G. Brancatelli, M. P. Federle, L. Grazioli, R. Golfieri, and R. Lencioni Benign Regenerative Nodules in Budd-Chiari Syndrome and Other Vascular Disorders of the Liver: Radiologic-Pathologic and Clinical Correlation RadioGraphics, July 1, 2002; 22(4): 847 - 862. [Abstract] [Full Text] [PDF]

				L. Grazioli, M. P. Federle, G. Brancatelli, T. Ichikawa, L. Olivetti, and A. Blachar Hepatic Adenomas: Imaging and Pathologic Findings RadioGraphics, July 1, 2001; 21(4): 877 - 892. [Abstract] [Full Text] [PDF]

				A. D. Levy and P. R. Ros Invited Commentary RadioGraphics, July 1, 2001; 21(4): 892 - 894. [Full Text] [PDF]